(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 19.01% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.56%.
Natera's revenue in 2026 is $2,306,113,000.On average, 25 Wall Street analysts forecast NTRA's revenue for 2026 to be $386,217,656,250, with the lowest NTRA revenue forecast at $367,792,593,750, and the highest NTRA revenue forecast at $400,815,975,000. On average, 24 Wall Street analysts forecast NTRA's revenue for 2027 to be $463,461,187,500, with the lowest NTRA revenue forecast at $430,296,075,000, and the highest NTRA revenue forecast at $504,421,518,750.
In 2028, NTRA is forecast to generate $553,602,262,500 in revenue, with the lowest revenue forecast at $492,232,631,250 and the highest revenue forecast at $634,814,268,750.